Figure 1
Potent combination benefit of EPZ-6438 with CHOP chemotherapy in the SUDHL6 EZH2 Y646N mutant mouse xenograft model. EPZ-6438 was dosed for 28 days by oral gavage as indicated. CHOP cycles were administered on days 1 and 8.
Potent combination benefit of EPZ-6438 with CHOP chemotherapy in the SUDHL6 EZH2 Y646N mutant mouse xenograft model. EPZ-6438 was dosed for 28 days by oral gavage as indicated. CHOP cycles were administered on days 1 and 8.
